Stocksigma LogoStocksigma Logo

Novartis India Enters Retina Segment via Exclusive Distribution Deal with NHPL

Novartis India Limited executed an Exclusive Promotion and Distribution Agreement on 8th Sep'26 with Novartis Healthcare Private Limited (NHPL) to

Novartis India Enters Retina Segment via Exclusive Distribution Deal with NHPL

Novartis India Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 3:23 pm

Novartis India Enters Retina Segment via Exclusive Distribution Deal with NHPL Novartis India Limited executed an Exclusive Promotion and Distribution Agreement on 8th Sep'26 with Novartis Healthcare Private Limited (NHPL) to exclusively market and distribute NHPL鈥檚 retina portfolio鈥攃omprising Accentrix (ranibizumab) and Pagenax (brolucizumab)鈥攊n India. Under the terms, the company will pay an upfront consideration of INR 10 Crores to NHPL. The transaction marks Novartis India's strategic entry into the ophthalmology therapy segment while expanding its commercial pharmaceutical portfolio. The agreement involves no promoter group relationship and is not classified as a related-party transaction.

Original exchange filing (PDF)

More announcements from Novartis India Ltd

All Novartis India Ltd announcements